InvestSMART

Aroa Biosurgery Limited (ASX: ARX) - Announcements

- Current share price for ARX : $0.555

ASX company news and announcements for Aroa Biosurgery Limited (ARX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Aroa Biosurgery Limited (ARX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Aroa Biosurgery Limited (ARX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Aroa Biosurgery Limited (ARX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$192 Notification of cessation of securities - ARX 13 Jan 2022 3:17PM $0.985 $0.555 fallen by 43.65%
$192 Application for quotation of securities - ARX 7 Dec 2021 4:41PM $1.055 $0.555 fallen by 47.39%
$192 Section 708A Notice 7 Dec 2021 4:37PM $1.055 $0.555 fallen by 47.39%
$192 Aroa Biosurgery Half Yearly Report Update Amendment 25 Nov 2021 9:06AM $1.150 $0.555 fallen by 51.74%
$192 Aroa Biosurgery Half Yearly Report H1 FY21 25 Nov 2021 8:32AM $1.150 $0.555 fallen by 51.74%
$192 Appendix 4D and Half Year Report 25 Nov 2021 8:27AM $1.150 $0.555 fallen by 51.74%
$192 New study extends understanding of AROA ECM 11 Nov 2021 10:09AM $1.150 $0.555 fallen by 51.74%
$192 Bell Potter Healthcare Conference Presentation - Nov 2021 9 Nov 2021 12:06PM $1.130 $0.555 fallen by 50.88%
$192 September Quarterly Report and Appendix 4C 27 Oct 2021 8:20AM $1.155 $0.555 fallen by 51.95%
$192 Notification of Quarterly Webinar 22 Oct 2021 9:10AM $1.130 $0.555 fallen by 50.88%
$192 Aroa delivers strong half, Myriad GPO win 6 Oct 2021 8:20AM $1.080 $0.555 fallen by 48.61%
$192 Ceasing to be a substantial holder 30 Aug 2021 4:06PM $1.070 $0.555 fallen by 48.13%
$192 Application for quotation of securities - ARX 25 Aug 2021 9:44AM $1.075 $0.555 fallen by 48.37%
$192 Section 708A Notice 25 Aug 2021 9:41AM $1.075 $0.555 fallen by 48.37%
$192 Allotment of Share Purchase Plan Shares 25 Aug 2021 9:41AM $1.075 $0.555 fallen by 48.37%
$192 Share Purchase Plan Offer Closes 23 Aug 2021 9:59AM $1.030 $0.555 fallen by 46.12%
$192 Change of Director's Interest Notice - JM 19 Aug 2021 4:08PM $1.040 $0.555 fallen by 46.63%
$192 Notification regarding unquoted securities - ARX 19 Aug 2021 4:05PM $1.040 $0.555 fallen by 46.63%
$192 Application for quotation of securities - ARX 19 Aug 2021 4:02PM $1.040 $0.555 fallen by 46.63%
$192 Section 708A Notice 19 Aug 2021 4:00PM $1.040 $0.555 fallen by 46.63%
$192 Substantial Holders Notification 12 Aug 2021 5:03PM $1.080 $0.555 fallen by 48.61%
$192 Change of Director's Interest Notice - PM 10 Aug 2021 11:40AM $1.110 $0.555 fallen by 50%
$192 New real-world data shows Endoform improves wound closure 10 Aug 2021 9:47AM $1.085 $0.555 fallen by 48.85%
$192 Application for quotation of securities - ARX 4 Aug 2021 9:51AM $1.145 $0.555 fallen by 51.53%
$192 Section 708A Cleansing Statement 4 Aug 2021 9:47AM $1.145 $0.555 fallen by 51.53%

251 - 275 of 765 results

Page 11 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.